Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT
NCT07319793
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Myelodysplastic Syndromes (MDS)
Interventions
OTHER:
Prophylactic DLI
OTHER:
Preemptive DLI
Sponsor
Peking University People's Hospital